Industries > Healthcare > Healthcare Competitive Intelligence (CI) Service

Healthcare Competitive Intelligence (CI) Service

Competitive intelligence in healthcare is an amalgamation of assessing the threat of new entrants, current players in the market (and their expansion/market positioning), power of suppliers and buyers, availability of substitutes and counterfeits, and competitive rivalry in the clients area of interest.

Blogs | Wearable Tech: A Promise to Revolutionize Healthcare

Why Healthcare Competitive Intelligence?

Competitive intelligence in healthcare is not a new concept. However, it is the new age mechanism to distinguish between ’information’ and ‘intelligence’. Competitive intelligence (CI) is being employed as a tool to convert information with intelligence into actionable insights for growth and new revenue.  

At SG Analytics (SGA), we understand that credible and legit information is the starting point. Digitization of payer and provider data has filled the public domain with statistics, numbers, and heaps of data about patients and their preferences, companies, drugs, medical equipment, and more. The surplus of information has created complexity in understanding the true essence of data; data is only considered ’intelligent’ when it is cleaned, filtered, and analyzed.  

SGA assists clients in establishing a link between this information and business strategies and decisions by offering alerts, region-and product-specific dashboards on CI, smart reports on competitors, and more. Our CI models have saved millions of dollars for our clients, and our samples can tell you more about the same.  

healthcare competitive intelligence

What We Offer

We, at SGA, understand our client's end goal and the objective for the exercise before initiating a work plan for healthcare competitive intelligence projects. Our experts speak your language and understand the threat, opportunities, as well as strengths of different therapeutic segments. 

Our experts understand and map peers on a company level as well as a product level. We track 5000 pharmaceutical companies and 800 key medical device companies daily to understand their launch strategies and pipelines, along with their roadmap. Our AI/ML tools (proprietary) are time-tested to compile insights quickly from the desired market. 

The team of data analysts at SGA is proficient in data crawling, gathering, cleansing, and sorting before diagnosing the insights from the most relevant information. 

SGA's strategy support team has been assisting our current customers with actionable insights on products, peers, and market perceptions. 


Industry Leader

SGA thrives by its brand promise Life is Possible, and is recognized as the most trusted healthcare market research company.

12+ Languages

SGAs language capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English experts (US/UK).

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we strive to deliver high-quality, efficient outputs.

End-to-End Solutioning

SGA has an in-house KOL (key opinion leader) capability of more than 700, along with analytical and ML/AI capabilities, which help in presenting credible competitive information.

Who We Work With


Whitepaper Market Entry in 2023

White Papers

Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?

Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...

SGA Whitepaper Blue Ocean Strategy

White Papers

The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?

Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....

SGA Healthcare Whitepaper Healthcare Consulting & Analytics

White Papers

What Happens When You Invest in Healthcare Consulting and Analytics?

Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...

We strongly believe in women power. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.

Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high quality, white labelled research coverage.